FEROSE 100/MG CHEW TAB 30/CHEW TAB

Benefits & Uses

Primary Benefit

Treats and prevents iron deficiency and iron deficiency anemia by replenishing iron stores required for hemoglobin formation and oxygen transport.

Health Claims

Supports formation of red blood cells and hemoglobin; contributes to reduction of tiredness and fatigue associated with iron deficiency; supports normal cognitive function and oxygen transport in the blood.

Common Deficiency Symptoms

Fatigue, pallor, shortness of breath, dizziness, cold hands and feet, brittle nails, pica, headache, poor concentration, and reduced exercise tolerance.

Target Population

Adults and children with iron deficiency anemia, pregnant and breastfeeding women, vegetarians and vegans, individuals with chronic blood loss (e.g., heavy menstrual bleeding), and patients with increased iron requirements.

Scientific Evidence Level

Strong

Onset Timeline

Hemoglobin levels typically begin to increase within 2-4 weeks of therapy; full replenishment of iron stores requires approximately 3-6 months of continued treatment.

Usage & Dosage

Suggested Use

Chew 1 tablet daily, during or immediately after a meal, or as directed by a physician.

Serving Size

1 chewable tablet.

Servings Per Container

30

Best Time to Take

With meals - iron polymaltose can be taken with food without significant reduction in absorption, unlike ferrous salts.

Recommended Daily Intake

Adults: 8-18mg/day (elemental iron); Pregnant women: 27mg/day; Therapeutic dose for iron deficiency anemia: 100-200mg elemental iron/day

Upper Tolerable Limit

45mg/day elemental iron for adults (from supplements); therapeutic doses above this level are used only under medical supervision.

Absorption Enhancers

Vitamin C (ascorbic acid) may modestly enhance absorption; taking with food is well tolerated without significantly reducing bioavailability.

Absorption Inhibitors

Calcium-rich foods, antacids, proton pump inhibitors, tetracycline antibiotics, fluoroquinolones, phytates (in cereals and grains), and polyphenols (in tea and coffee) may reduce absorption; separate administration by at least 2 hours.

Side Effects

Possible Side Effects

Generally well-tolerated; may cause dark or black stools (harmless), mild nausea, constipation, or diarrhea. Gastrointestinal side effects are significantly less frequent than with ferrous salt formulations.

Toxicity Risk

Low

Upper Tolerable Limit

45mg/day elemental iron for adults (from supplements); therapeutic doses above this level are used only under medical supervision.

Safety & Warnings

Contraindications

Contraindicated in iron overload states (e.g., hemochromatosis, hemosiderosis) and in anemia not caused by iron deficiency / disorders of iron utilization (e.g., hemolytic anemia, sideroblastic anemia, thalassemia), and in patients with known hypersensitivity to iron polymaltose or any excipient.

Pregnancy Safety

Consult Doctor

Breastfeeding Safety

Safe

Children Suitability

Dosage for children must be determined by a physician based on weight and age. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 - keep out of reach of children.

Interactions

Medication Interactions

Iron Polymaltose Complex has minimal to no clinically significant interactions with tetracyclines or antacids compared to ferrous salts; however, co-administration with parenteral (injectable) iron is contraindicated. May reduce absorption of levothyroxine and levodopa - separate by at least 2 hours.

Supplement Interactions

Calcium supplements interfere with iron absorption; take at different times. Zinc and magnesium at high doses may compete for absorption pathways.

Synergistic Nutrients

Vitamin C enhances iron absorption by maintaining iron in its reduced form; Vitamin B12 and folate support red blood cell formation alongside iron.

Special Populations

Target Population

Adults and children with iron deficiency anemia, pregnant and breastfeeding women, vegetarians and vegans, individuals with chronic blood loss (e.g., heavy menstrual bleeding), and patients with increased iron requirements.

Children Suitability

Dosage for children must be determined by a physician based on weight and age. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 - keep out of reach of children.

Pregnancy Safety

Consult Doctor

Breastfeeding Safety

Safe

Storage & Patient Advice

SFDA Storage Conditions

store below 30°c

Storage Conditions

Store below 30°C in a dry place, away from direct sunlight and out of reach of children. Shelf life: 36 months.

Patient Counseling

Chew the tablet thoroughly before swallowing. Take with or after food if stomach upset occurs (iron polymaltose may be taken with meals). Dark/black stools can occur and are harmless. Separate from interacting oral medicines that reduce absorption by at least 2 hours (e.g., antacids/calcium/other mineral supplements; tetracyclines; fluoroquinolones; levothyroxine; bisphosphonates; penicillamine; methyldopa/levodopa). Continue therapy for the full recommended course to replenish iron stores even after symptoms improve. Keep out of reach of children-accidental iron overdose can be fatal; seek urgent care/poison control if overdose is suspected or if severe/persistent abdominal pain or vomiting occurs. Do not take at the same time as parenteral (injectable) iron unless specifically directed by a clinician.

Science & Evidence

Bioavailability Form

Iron (III) hydroxide polymaltose complex - a non-ionic form that mimics natural ferritin, leading to controlled iron absorption and significantly fewer gastrointestinal side effects compared to conventional ferrous salts.

Scientific Evidence Level

Strong

Onset Timeline

Hemoglobin levels typically begin to increase within 2-4 weeks of therapy; full replenishment of iron stores requires approximately 3-6 months of continued treatment.

Food Sources

Heme iron: red meat, liver, poultry, and fish. Non-heme iron: lentils, beans, tofu, spinach, pumpkin seeds, and fortified cereals.

Product Information

Supplement Type

Mineral

Certification

SFDA registered (Registration No. 2110258450); manufactured by SPIMACO ADDWAEIH, Saudi Arabia, under GMP standards.

Iron Form

Iron Polymaltose Complex (IPC)

Elemental Iron Mg

100